YBX1 and neoplasm: Collectively, these results suggested that high level of YBX1 may confer “cold” tumor immune phenotype, characterized by reduced abundance of infiltrating leukocytes, diminished immune cell activation and emergence of immunosuppressive signaling, which might represent a promising therapeutic target.